Paper33463549
Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.
Sharma R and 16 others. J Clin Invest, 2021. Cited by 179 papers, by iCite.
Cite this record
ConductScience Library. Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity. Papers, record 33463549. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33463549
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MELAS Syndrome | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Alanine | |
| Biomarkers | |
| Child | |
| Child, Preschool | |
| Female | |
| Growth Differentiation Factor 15 | |
| Humans | |
| Hydroxybutyrates | |
| Lactic Acid | |
| Male | |
| Middle Aged | |
| Mutation | |
| Severity of Illness Index |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F32 GM133047 | NIGMS NIH HHS | United States | F32GM133047 | PubMed and NIH | NIH RePORTER |
| P01 HD080642 | NICHD NIH HHS | United States | P01HD080642 | PubMed and NIH | NIH RePORTER |
| P30 DK040561 | NIDDK NIH HHS | United States | P30DK040561 | PubMed and NIH | NIH RePORTER |
| R01 AR050597 | NIAMS NIH HHS | United States | R01AR050597 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 33463543 | Proteomic and metabolomic advances uncover biomarkers of mitochondrial disease pathophysiology and severity. | https://conductscience.org/library/papers/33463543 |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29735722 | mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease. | EMBO Mol Med | 2018 | https://conductscience.org/library/papers/29735722 | PubMed |
| 2 | 6093682 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. | Ann Neurol | 1984 | https://conductscience.org/library/papers/6093682 | PubMed |
| 3 | 29980632 | Emerging therapies for mitochondrial diseases. | Essays Biochem | 2018 | https://conductscience.org/library/papers/29980632 | PubMed |
| 4 | 30874790 | Elevated Plasma Growth and Differentiation Factor 15 Is Associated With Slower Gait Speed and Lower Physical Performance in Healthy Community-Dwelling Adults. | J Gerontol A Biol Sci Med Sci | 2020 | https://conductscience.org/library/papers/30874790 | PubMed |
| 5 | 17300999 | Population prevalence of the MELAS A3243G mutation. | Mitochondrion | 2007 | https://conductscience.org/library/papers/17300999 | PubMed |
| 6 | 30810978 | The Effect of 2-Ketobutyrate on Mitochondrial Substrate-Level Phosphorylation. | Neurochem Res | 2019 | https://conductscience.org/library/papers/30810978 | PubMed |
| 7 | 31932725 | An engineered enzyme that targets circulating lactate to alleviate intracellular NADH:NAD+ imbalance. | Nat Biotechnol | 2020 | https://conductscience.org/library/papers/31932725 | PubMed |
| 8 | 21700882 | Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21700882 | PubMed |
| 9 | 19204268 | Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation. | Neurology | 2009 | https://conductscience.org/library/papers/19204268 | PubMed |
| 10 | 2102678 | A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. | Nature | 1990 | https://conductscience.org/library/papers/2102678 | PubMed |
| 11 | 12427892 | Diagnostic criteria for respiratory chain disorders in adults and children. | Neurology | 2002 | https://conductscience.org/library/papers/12427892 | PubMed |
| 12 | 30089816 | Mitochondrial DNA m.3243A > G heteroplasmy affects multiple aging phenotypes and risk of mortality. | Sci Rep | 2018 | https://conductscience.org/library/papers/30089816 | PubMed |
| 13 | 26867126 | GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction. | PLoS One | 2016 | https://conductscience.org/library/papers/26867126 | PubMed |
| 14 | 21443929 | MELAS: a nationwide prospective cohort study of 96 patients in Japan. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/21443929 | PubMed |
| 15 | 12832613 | Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12832613 | PubMed |
| 16 | 25446397 | GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases. | Mitochondrion | 2015 | https://conductscience.org/library/papers/25446397 | PubMed |
| 17 | 19622376 | Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. | J Biotechnol | 2009 | https://conductscience.org/library/papers/19622376 | PubMed |
| 18 | 28716914 | Metabolic profiles of exercise in patients with McArdle disease or mitochondrial myopathy. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28716914 | PubMed |
| 19 | 31218894 | Metabolic Responses to Reductive Stress. | Antioxid Redox Signal | 2020 | https://conductscience.org/library/papers/31218894 | PubMed |
| 20 | 11085913 | Decrease of 3243 A-->G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. | Am J Hum Genet | 2001 | https://conductscience.org/library/papers/11085913 | PubMed |
Cited by134
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 179 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42988808 | Multi-omics profiling uncovers diagnostic biomarker panel, progression-associated subtypes, and prognostic signature in pediatric mitochondrial disease. | Nat Commun | 2026 | https://conductscience.org/library/papers/42988808 | PubMed |
| 42913628 | MCT6 is an intestinal Lac-Phe exporter required for metformin-associated weight loss. | Cell | 2026 | https://conductscience.org/library/papers/42913628 | PubMed |
| 42903923 | Context-specific hypermetabolism in humans with mitochondrial defects. | Cell Press Blue | 2026 | https://conductscience.org/library/papers/42903923 | PubMed |
| 42817721 | Advances in diagnosis of mitochondrial dysfunction and primary mitochondrial disease. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/42817721 | PubMed |
| 42779741 | Systematic Engineering of Loss-of-Function Alleles in the Zebrafish Mitochondrial Proteome. | bioRxiv | 2026 | https://conductscience.org/library/papers/42779741 | PubMed |
| 42650043 | Advances in Primary Mitochondrial Diseases: Diagnosis, Natural History Studies and Clinical Trials. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42650043 | PubMed |
| 42645669 | The Reductive Stress Nexus: Integrated Pathways of Metabolic Dysregulation, Senescence and Blood-Brain Barrier Failure in Neurodegenerative Disease and Brain Aging. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/42645669 | PubMed |
| 42622690 | Cross-species urinary metabolomics identifies 2-hydroxyisovalerate as a candidate biomarker for mtDNA-based disorders. | Metabolomics | 2026 | https://conductscience.org/library/papers/42622690 | PubMed |
| 42455203 | Karnofsky performance scale and modified Rankin scale as indicators of functional capacity in patients with mitochondrial disease. | Neurol Sci | 2026 | https://conductscience.org/library/papers/42455203 | PubMed |
| 42352315 | Reductive Stress and Ferroptosis: Linking Insulin Signaling to Metabolic Dysfunction. | Biomolecules | 2026 | https://conductscience.org/library/papers/42352315 | PubMed |
| 42331744 | Lactate as a Chemical Modification on Proteins and Metabolites. | Annu Rev Biochem | 2026 | https://conductscience.org/library/papers/42331744 | PubMed |
| 42318641 | From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial Diseases. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42318641 | PubMed |
| 42203880 | Mechanism of age-related accumulation of mtDNA mutations in human blood. | Nature | 2026 | https://conductscience.org/library/papers/42203880 | PubMed |
| 42203840 | Mapping the GDF15 arm of the integrated stress response in human cells and tissues. | Commun Biol | 2026 | https://conductscience.org/library/papers/42203840 | PubMed |
| 42072083 | The Emerging Role of N-Lactoyl-Phenylalanine (Lac-Phe) in Metabolic Regulation and Disease: From Exercise-Induced Metabolite to Therapeutic Candidate. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42072083 | PubMed |
| 41961121 | Non-invasive biomarkers for diagnosis and monitoring of primary mitochondrial diseases. | J Neurol | 2026 | https://conductscience.org/library/papers/41961121 | PubMed |
| 41911638 | Why is the tumor microenvironment disordered by NADH/NAD+ imbalance and how can we intervene? | Redox Biol | 2026 | https://conductscience.org/library/papers/41911638 | PubMed |
| 41756425 | Recessive PPTC7 deficiency triggers excessive mitophagy to cause a severe inborn error of metabolism with hypomyelinating leukodystrophy. | Res Sq | 2026 | https://conductscience.org/library/papers/41756425 | PubMed |
| 41727150 | 4,5-dihydroxyhexanoic acid is a robust circulating and urine marker of mitochondrial disease and its severity. | bioRxiv | 2026 | https://conductscience.org/library/papers/41727150 | PubMed |
| 41717224 | Changes in the brain [NAD+]/[NADH] and [NADPH]/[NADP+] with aging and anti-aging dietary restriction. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/41717224 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GDF15 | 9518 | PubTator's text mining | https://conductscience.org/library/genes/9518 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33463549
GET https://conductscience.org/api/papers/v1/33463549/references?page=2